Psychiatric comorbidity in women with polycystic ovary syndrome

Journal of Obstetrics and Gynaecology Research

Volumn 41, Issue 8, 2015, Pages 1229-1233

  Annagür, Bilge Burçak ^a   Kerimoglu, Özlem Seçilmiş ^a   Tazegül, Aybike ^a   Gündüz, Şule ^a   Gençoglu, Berat Berrin ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

anxiety; depression; hyperandrogenism; polycystic ovary syndrome; psychiatric comorbidity

Indexed keywords

ADULT; ARTICLE; BINGE EATING DISORDER; BLOOD SAMPLING; BODY MASS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DSM-IV; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MENTAL DISEASE; OVARY POLYCYSTIC DISEASE; SCORING SYSTEM; STRUCTURED INTERVIEW; ANXIETY DISORDERS; BINGE-EATING DISORDER; DEPRESSIVE DISORDER, MAJOR; PSYCHOLOGY;

ADULT; ANXIETY DISORDERS; BINGE-EATING DISORDER; BODY MASS INDEX; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; POLYCYSTIC OVARY SYNDROME;

EID: 84938198600     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/jog.12696     Document Type: Article

References (32)

1. Franks S., Polycystic ovary syndrome. N Engl J Med 1995; 333: 853-861.
2. Dunaif A, Segal KR, Futterweit W, Dobrjansky A,. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989; 38: 1165-1174.
3. Arslanian SA, Lewy VD, Danadian K,. Glucose intolerance in obese adolescents with polycystic ovary syndrome: Roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease. J Clin Endocrinol Metab 2001; 86: 66-71.
4. Nestler JE, Jakubowicz DJ,. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 1996; 335: 617-623.
5. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO,. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89: 2745-2749.
6. Stunkard AJ, Faith MS, Allison KC,. Depression and obesity. Biol Psychiatry 2003; 54: 330-337.
7. Fassino S, Leombruni P, Pierò A, Abbate-Daga G, Giacomo Rovera G,. Mood, eating attitudes, and anger in obese women with and without binge eating disorder. J Psychosom Res 2003; 54: 559-566.
8. Simon GE, Ludman EJ, Linde JA, et al,. Association between obesity and depression in middle-aged women. Gen Hosp Psychiatry 2008; 30: 32-39.
9. Okamura F, Tashiro A, Utumi A, et al,. Insulin resistance in patients with depression and its changes during the clinical course of depression: Minimal model analysis. Metabolism 2000; 49: 1255-1260.
10. Chiba M, Suzuki S, Hinokio Y, et al,. Tyrosine hydroxylase gene microsatellite polymorphism associated with insulin resistance in depressive disorder. Metabolism 2000; 49: 1145-1149.
11. Timonen M, Laakso M, Jokelainen J, Rajala U, Meyer-Rochow VB, Keinänen-Kiukaanniemi S,. Insulin resistance and depression: Cross sectional study. BMJ 2005; 330: 17-18.
12. Rasgon NL, Rao RC, Hwang S, et al,. Depression in women with polycystic ovary syndrome: clinical and biochemical correlates. J Affect Disord 2003; 74: 299-304.
13. Pastore LM, Patrie JT, Morris WL, et al,. Depression symptoms and body dissatisfaction association among polycystic ovary syndrome women. J Psychosom Res 2011; 71: 270-276.
14. de Niet JE, de Koning CM, Pastoor H, et al,. Psychological well-being and sexarche in women with polycystic ovary syndrome. Hum Reprod 2010; 25: 1497-1503.
15. Coffey S, Bano G, Mason HD,. Health-related quality of life in women with polycystic ovary syndrome: A comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36). Gynecol Endocrinol 2006; 22: 80-86.
16. Elsenbruch S, Hahn S, Kowalsky D, et al,. Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003; 88: 5801-5807.
17. Himelein MJ, Thatcher SS,. Depression and body image among women with polycystic ovary syndrome. J Health Psychol 2006; 11: 613-625.
18. Rassi A, Veras AB, dos Reis M, et al,. Prevalence of psychiatric disorders in patients with polycystic ovary syndrome. Compr Psychiatry 2010; 51: 599-602.
19. Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A,. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril 2007; 87: 1369-1376.
20. Morgan JF, McCluskey SE, Brunton JN, Hubert Lacey J,. Polycystic ovarian morphology and bulimia nervosa: A 9-year follow-up study. Fertil Steril 2002; 77: 928-931.
21. First MB, Spitzer RL, Gibbon M, Williams JBW,. Structured Clinical Interview for DSM-IV Clinical Version (SCID-I/CV). Washington, DC: American Psychiatric Press, 1997.
22. Özkürkçügil A, Aydemir Ö, Ybox drawings light down and leftldbox drawings light down and leftz M, Danacbox drawings light down and left AE, Köroʇlu E,. DSM-IV Eksen I bozukluklarbox drawings light down and left için yapbox drawings light down and leftlandbox drawings light down and leftrbox drawings light down and leftlmbox drawings light down and leftş klinik görüşmenin Türkçe'ye uyarlanmasbox drawings light down and left ve güvenilirlik çalbox drawings light down and leftşmasbox drawings light down and left. ̄laç ve Tedavi Dergisi 1999; 12: 233-236. (In Turkish.)
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC,. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
24. Månsson M, Holte J, Landin-Wilhelmsen K, Dahlgren E, Johansson A, Landén M,. Women with polycystic ovary syndrome are often depressed or anxious: A case control study. Psychoneuroendocrinology 2008; 33: 1132-1138.
25. Weber B, Lewicka S, Deuschle M, Colla M, Heuser I,. Testosterone, androstenedione and dihydrotestosterone concentrations are elevated in female patients with major depression. Psychoneuroendocrinology 2000; 25: 765-771.
26. Baischer W, Koinig G, Hartmann B, Huber J, Langer G,. Hypothalamic-pituitary-gonadal axis in depressed premenopausal women: Elevated blood testosterone concentrations compared to normal controls. Psychoneuroendocrinology 1995; 20: 553-559.
27. Barnard L, Ferriday D, Guenther N, Strauss B, Balen AH, Dye L,. Quality of life and psychological well-being in polycystic ovary syndrome. Hum Reprod 2007; 22: 2279-2286.
28. Figlewicz DP,. Endocrine regulation of neurotransmitter transporters. Epilepsy Res 1999; 37: 203-210.
29. Raphael FJ, Rodin DA, Peattie A, et al,. Ovarian morphology and insulin sensitivity in women with bulimia nervosa. Clin Endocrinol 1995; 43: 451-455.
30. Cotrufo P, Monteleone P, d'Istria M, Fuschino A, Serino I, Maj M,. Aggressive behavioral characteristics and endogenous hormones in women with bulimia nervosa. Neuropsychobiology 2000; 42: 58-61.
31. Naessén S, Carlström K, Byström B, Pierre Y, Hirschberg AL,. Effects of an antiandrogenic oral contraceptive on appetite and eating behavior in bulimic women. Psychoneuroendocrinology 2007; 32: 548-554.
32. Fandiño J, Moreira RO, Preissler C, et al,. Impact of binge eating disorder in the psychopathological profile of obese women. Compr Psychiatry 2010; 51: 110-114.